Search Within

Pedram Razavi

Formats
  1. Meeting Abstract (85)
  2. Journal Article (81)
  3. Editorial (2)
  4. Research Letter (2)
  5. Review (2)
  6. Guidelines (1)
Groups
  1. Breast Medicine Service (173)
  2. Department of Medicine (173)
  3. Solid Tumor Oncology Division (173)
  4. Weinberg Fellows (173)
  5. GSK Faculty (150)
  6. Human Oncology and Pathogenesis Program (122)

More Groups

People
  1. Sarat Chandarlapaty (74)
  2. Jorge Reis-Filho (66)
  3. Michael Berger (45)
  4. Bob Li (41)
  5. David Solit (37)
  6. Dara Ross (32)

More People

Years
  1. 2025 (7)
  2. 2024 (24)
  3. 2023 (11)
  4. 2022 (25)
  5. 2021 (15)
  6. 2020 (38)

More Years

Publications
  1. Journal of Clinical Oncology (35)
  2. Cancer Research (26)
  3. Modern Pathology (9)
  4. Annals of Oncology (8)
  5. Cancer Discovery (7)
  6. International Journal of Radiation Oncology, Biology, Physics (7)

More Publications

Publishers
  1. American Association for Cancer Research (40)
  2. American Society of Clinical Oncology (40)
  3. Nature Publishing Group (27)
  4. Elsevier Inc. (12)
  5. Cell Press (11)
  6. Nature Research (11)

More Publishers

Results (173)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Real-world outcomes with adjuvant nonsteroidal aromatase inhibitors (NSAIs) vs tamoxifen (TAM) in patients with hormone receptor−positive/human epidermal growth factor receptor 2−negative (HR+/HER2−) early breast cancer (EBC): A US database analysis
    Meeting Abstract

    Graff, S. L.; Tolaney, S. M.; Hart, L.L.; Razavi, P.; Fasching, P.A.; Janni, W.; Schwartzberg, L. S.; Lanoue, B.; Romero Salas, T.; Khakwani, A.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Genomic analysis and clinical correlations of non-small cell lung cancer brain metastasis
    Journal Article

    Skakodub, A.; Walch, H.; Tringale, K. R.; Eichholz, J.; Imber, B. S.; Vasudevan, H. N.; Li, B. T.; Moss, N. S.; Hei Yu, K. K.; Mueller, B. A.; more...
    Nature Communications (2023)

    Fulltext@MSK | Save
  • NR2F2 mediates cell growth and endocrine resistance in NF1 loss, ER+ breast cancer
    Meeting Abstract

    Cai, Y.; Zhao, P.; Wu, F.; Shao, H.; Razavi, P.; Xu, G.; Scaltriti, M.; Chandarlapaty, S.
    Cancer Research (2022)

    Fulltext@MSK | Save
  • Statin therapy enhances the efficacy of HER2 directed antibody-drug conjugates in breast cancer
    Meeting Abstract

    Liu, B.; Drago, J. Z.; Rao, Y.; Pereira, P. R.; Safonov, A.; Marra, A.; Ahmed, M. S.; Modi, S.; Reis, J. S.; Montemurro, F.; more...
    Cancer Research (2022)

    Fulltext@MSK | Save
  • Prediction of neoadjuvant treatment outcomes with multimodal data integration in breast cancer
    Meeting Abstract

    Khosravi, P.; Sutton, E. J.; Jee, J.; Dalfonso, T.; Fong, C. J.; Rose, D.; Da Silva, E. M.; Kohli, A.; Ho, D. J.; Ahmed, M. S.; more...
    Cancer Research (2022)

    Fulltext@MSK | Save
  • Mutational signature analysis reveals patterns of genomic instability linked to resistance to endocrine therapy (ET) +/- CDK 4/6 inhibition (CDK4/6i) in estrogen receptor-positive/HER2-negative (ER+/HER2-) metastatic breast cancer (MBC)
    Meeting Abstract

    Marra, A.; Gazzo, A.; Gupta, A.; Selenica, P.; Da Silva, E. M.; Pareja, F.; Pei, X.; Zhu, Y.; Razavi, P.; Safonov, A.; more...
    Annals of Oncology (2022)

    Fulltext@MSK | Save
  • Use of real-world data (RWD) to assess the utility of cell-free circulating tumor DNA (cfDNA) in identifying resistance to early treatment in advanced breast cancer (aBC)
    Meeting Abstract

    Wander, S. A.; Weipert, C.; Liao, J.; Zhang, N.; Razavi, P.
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Impact of clonal hematopoiesis on tumor control following radiation therapy
    Meeting Abstract

    Tao, J.; Setton, J.; Vela, P. S.; Safonov, A. M.; Comen, E. A.; Braunstein, L. Z.; Reis-Filho, J. S.; Riaz, N.; Powell, S. N.; Levine, R. L.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Allelic dosage of RB1 drives CDK4/6 inhibitor treatment resistance in metastatic breast cancer
    Meeting Abstract

    Safonov, A. M.; Bandlamudi, C.; Selenica, P.; Marra, A.; Ferraro, E.; Mandelker, D.; Solit, D. B.; Berger, M. F.; Norton, L.; Powell, S. N.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Minimal residual disease (MRD) detection by ctDNA in relation to radiographic disease progression in patients with stage I-III non-small cell lung cancer (NSCLC) treated with definitive radiation therapy
    Meeting Abstract

    Lebow, E. S.; Murciano-Goroff, Y. R.; Jee, J.; Kalashnikova, E.; Feeney, J.; Sethi, H.; Aleshin, A.; Kris, M. G.; Chaft, J. E.; Rudin, C. M.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save